您的位置:PharmaNews 研发动态 正文
内容搜索
热门内容
推荐内容
最新内容
反馈意见和建议

Covance Reports Second Quarter Revenue of $475M and EPS of $0.49; Updates Full-Year Financial Targets(8)
本文章共23214字,分15页,当前第8页,快速翻页:


  Income before taxes and equity investee
  earnings                                    93,602          115,723  (a)
  Taxes on income                              23,469          32,400  (a)
  Equity investee earnings (loss)                673              (38)
  Net income                                  $70,806          $83,285  (a)
                                              =======          =======
  Basic earnings per share                      $1.11            $1.31  (a)
  Weighted average shares outstanding -
  basic                                  63,531,999      63,705,105
  Diluted earnings per share                    $1.09            $1.30  (a)
  Weighted average shares outstanding -
  diluted                                65,058,693      64,024,143
  (a) Includes the impact of a $655 gain on sale of Cardiac Safety
  Services ($426 net of tax) during the second quarter of 2009.



  Excluding the impact of the gain on sale
  of business:
  ----------------------------------------
  Income before taxes and equity investee
  earnings                                        $41,826        $58,596
  Taxes on income                                  $10,415        $15,822
  Net income                                        $31,665        $42,564
  Basic earnings per share                            $0.50          $0.67
  Diluted earnings per share                          $0.49          $0.66




  Excluding the impact of the gain on sale

 

 

点这里复制本页地址     发送给您QQ/MSN上的好友


相关文章

  Commonwealth Biotechnologies, Inc. Provi

Quintiles Announces New European Headqua

FDA Approves Drug for Chronic Drooling i

Abbott's Simcor ( niacin extended-releas

Abraxis BioScience and Specialised Thera

Shionogi Inc. Announces FDA Approval of

Researchers Solve Mystery of Uner Tan Sy

WaferGen Announces Purchase of SmartChip

Plant Compound Resveratrol Shown to Supp

New pathway to Parkinson's and Alzheimer

deCODE Shows how Genetic Risk of Kidney

相关评论

    
本文章所属分类:首页 研发动态